Byotrol Secures £60,000 Contract

Byotrol plc
                  

BYOTROL SECURES MAJOR CONTRACT WITH IRISH HEALTHCARE DISTRIBUTOR WORTH £60,000

Byotrol ('the Company') is pleased to announce it has secured a major contract
to supply its technology to Irish based healthcare company Audit Diagnostics.

Audit Diagnostics is a leading global supplier of diagnostic equipment and
ancillary products to hospital and medical laboratories.

The contract will see Byotrol products used in hospital and medical laboratories
worldwide and has an initial order value of £60,000 (€100,000). Byotrol's
technology will be incorporated into a range of anti-bacterial wipes, sprays and
mousses and these will be marketed under Audit Diagnostics Sterl STAT brand.

The product range will be co-branded with Byotrol positioned as an ingredient
brand in line with the Company's corporate brand development strategy.

The Company is confident that this is the first in a series of potential future
orders from Audit Diagnostics.

Stephen Falder, Business Development Director for Byotrol, comments, 'Hospital
and medical laboratories are extremely demanding environments from an infection
control perspective and much of the knowledge on infection control resides
within the laboratory and infection control teams. This contract win means our
products will be used in an extremely demanding environment and this will
hopefully pave the way for wider adoption of our technology across the UK and
beyond in the healthcare market. This is excellent news and represents
tremendous progress for the business within the healthcare sector.'
Financial calls to:
Stephen Falder
Byotrol plc
0870 609 4480
   Or
Oli Rayner
Merchant Capital
0207 332 2200

Media calls to:
Jim Rothnie
McCann Erickson PR
T: 01625 822540
E: [e-mail]